Rocket Pharmaceuticals, Inc. (RCKT) financial statements (2023 and earlier)
Company profile
| Business Address |
350 FIFTH AVENUE NEW YORK, NY 10118 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 388,700 | 421,500 | 426,800 | 466,400 | 482,700 | 228,700 | 249,800 | ||
| Cash and cash equivalents | 232,694 | 245,644 | 264,608 | 252,540 | 297,098 | 82,226 | 163,203 | ||
| Short-term investments | 156,046 | 175,815 | 162,222 | 213,813 | 185,621 | 146,464 | 86,600 | ||
| Other undisclosed cash, cash equivalents, and short-term investments | (40) | 41 | (30) | 47 | (19) | 10 | (3) | ||
| Other undisclosed current assets | 3,359 | 3,569 | 3,626 | 5,422 | 4,645 | 4,514 | 5,636 | ||
| Total current assets: | 392,059 | 425,069 | 430,426 | 471,822 | 487,345 | 233,214 | 255,436 | ||
| Noncurrent Assets | |||||||||
| Finance lease, right-of-use asset | 48,480 | 49,011 | 49,507 | 50,311 | 50,521 | 52,547 | 49,250 | ||
| Operating lease, right-of-use asset | 1,569 | 1,467 | 1,628 | 1,787 | 914 | 1,094 | 1,270 | ||
| Property, plant and equipment | 22,299 | 22,090 | 20,989 | 19,833 | 19,206 | 15,803 | 14,314 | ||
| Intangible assets, net (including goodwill) | 30,815 | 30,815 | 30,815 | 30,815 | 30,815 | 30,815 | 30,815 | ||
| Goodwill | 30,815 | 30,815 | 30,815 | 30,815 | 30,815 | 30,815 | 30,815 | ||
| Deposits noncurrent assets | 455 | 455 | 455 | 455 | 455 | 455 | 455 | ||
| Restricted cash and investments | 1,343 | 1,334 | 1,334 | 1,461 | 1,568 | 1,568 | 1,525 | ||
| Total noncurrent assets: | 104,961 | 105,172 | 104,728 | 104,662 | 103,479 | 102,282 | 97,629 | ||
| TOTAL ASSETS: | 497,020 | 530,241 | 535,154 | 576,484 | 590,824 | 335,496 | 353,065 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 19,615 | 22,008 | 17,884 | 33,168 | 25,472 | 24,830 | 18,245 | ||
| Accounts payable | 725 | 1,106 | 1,272 | 337 | 1,456 | 5,627 | 3,958 | ||
| Accrued liabilities | 1,678 | 1,847 | 1,404 | 2,287 | 2,167 | 1,439 | 1,099 | ||
| Employee-related liabilities | 4,533 | 3,815 | 3,115 | 6,187 | 4,875 | 2,796 | 2,072 | ||
| Interest and dividends payable | 123 | 449 | 1,122 | 620 | 1,252 | ||||
| Other undisclosed accounts payable and accrued liabilities | 12,679 | 15,240 | 11,970 | 23,908 | 15,852 | 14,348 | 9,864 | ||
| Debt | 1,689 | 1,677 | 6,768 | 6,641 | 6,519 | 6,397 | 1,621 | ||
| Other undisclosed current liabilities | 863 | 804 | 792 | 683 | 626 | 728 | 819 | ||
| Total current liabilities: | 22,167 | 24,489 | 25,444 | 40,492 | 32,617 | 31,955 | 20,685 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 20,049 | 20,000 | 20,166 | 55,871 | 54,552 | 61,677 | 65,834 | ||
| Long-term debt, excluding current maturities | 35,544 | 35,066 | 42,132 | 46,228 | |||||
| Finance lease, liability | 19,144 | 19,109 | 19,070 | 19,028 | 18,988 | 18,946 | 18,900 | ||
| Operating lease, liability | 905 | 891 | 1,096 | 1,299 | 498 | 599 | 706 | ||
| Liabilities, other than long-term debt | 80 | 94 | 107 | 122 | 136 | 23 | 23 | ||
| Other liabilities | 80 | 94 | 107 | 122 | 136 | 23 | 23 | ||
| Total noncurrent liabilities: | 20,129 | 20,094 | 20,273 | 55,993 | 54,688 | 61,700 | 65,857 | ||
| Total liabilities: | 42,296 | 44,583 | 45,717 | 96,485 | 87,305 | 93,655 | 86,542 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 454,724 | 485,658 | 489,437 | 479,999 | 503,519 | 241,841 | 266,523 | ||
| Common stock | 645 | 644 | 634 | 619 | 610 | 552 | 551 | ||
| Treasury stock, value | (76) | ||||||||
| Additional paid in capital | 946,152 | 932,776 | 886,431 | 842,477 | 825,794 | 503,223 | 498,590 | ||
| Accumulated other comprehensive income (loss) | (161) | (97) | (81) | (75) | (42) | 69 | 229 | ||
| Accumulated deficit | (491,912) | (447,665) | (397,547) | (363,022) | (322,843) | (261,927) | (232,847) | ||
| Total stockholders' equity: | 454,724 | 485,658 | 489,437 | 479,999 | 503,519 | 241,841 | 266,523 | ||
| TOTAL LIABILITIES AND EQUITY: | 497,020 | 530,241 | 535,154 | 576,484 | 590,824 | 335,496 | 353,065 | ||
Income statement (P&L) ($ in thousands)
| 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Gross profit: | (400) | (200) | (300) | |||||
| Operating expenses | (44,333) | (49,646) | (34,048) | (39,222) | (59,238) | (27,387) | (23,559) | |
| Other undisclosed operating income | 400 | 200 | 300 | |||||
| Operating loss: | (44,333) | (49,646) | (34,048) | (39,222) | (59,238) | (27,387) | (23,559) | |
| Interest and debt expense | (463) | (534) | (251) | (1,729) | (1,641) | (1,967) | (1,786) | |
| Net loss: | (44,796) | (50,180) | (34,299) | (40,951) | (60,879) | (29,354) | (25,345) | |
| Other undisclosed net income (loss) attributable to parent | 549 | 62 | (226) | 772 | (37) | 274 | 305 | |
| Net loss available to common stockholders, diluted: | (44,247) | (50,118) | (34,525) | (40,179) | (60,916) | (29,080) | (25,040) | |
Comprehensive Income ($ in thousands)
| 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (44,796) | (50,180) | (34,299) | (40,951) | (60,879) | (29,354) | (25,345) | |
| Comprehensive loss: | (44,796) | (50,180) | (34,299) | (40,951) | (60,879) | (29,354) | (25,345) | |
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 485 | 46 | (232) | 739 | (148) | 114 | 609 | |
| Comprehensive loss, net of tax, attributable to parent: | (44,311) | (50,134) | (34,531) | (40,212) | (61,027) | (29,240) | (24,736) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.